Sustained Clinical Response to 4th-Line Therapy with Selpercatinib in RET Fusion-Positive Combined Small Cell Lung Cancer

OBJECTIVE: Combined small cell lung cancer (C-SCLC) is a relatively rare subtype of small cell lung cancer (SCLC) which combines SCLC and any component of non-small cell carcinoma (NSCLC). Patients diagnosed with C-SCLC are currently recommended to receive the same treatment as SCLC cases in the abs...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yan, Dai, Shuang, Yin, Wenlian, Luo, Feng, Li, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693826/
https://www.ncbi.nlm.nih.gov/pubmed/38050583
http://dx.doi.org/10.2147/OTT.S440610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693826/
https://www.ncbi.nlm.nih.gov/pubmed/38050583
http://dx.doi.org/10.2147/OTT.S440610

Ejemplares similares